Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Cancer treatment consultancy Physiomics warned it would post a worse-than-expected full-year loss.
Physiomics said net losses for the year through June were likely to be in the range of £0.17 million-to-£0.20 million, on revenue of £0.70 million-to-£0.80 million.
'This is below market expectations and due to both Covid-related project delays and to an increased focus on longer-term value-generating activities,' it said.
The company said its cash position remained 'strong', with a net asset position at 30 June estimated to be around £1.1 million, the majority in cash.
At 8:48am: (LON:PYC) Physiomics PLC share price was 0p at 6.1p